Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
Journal of Neurosurgery
|
May 18, 2019
Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome
Marco Rossi, Federico Ambrogi, Lorenzo Gay, et al.
Neuro-Oncology
|
October 15, 2021
IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups
Roberta Rudà, Francesco Bruno, Tamara Ius, et al.
Radiation Oncology (London, England)
|
June 3, 2016
Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection
Pierina Navarria, Federico Pessina, Luca Cozzi, et al.
World Neurosurgery
|
February 25, 2019
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors
Marco Riva, Egesta Lopci, Antonella Castellano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2019
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study
Pierina Navarria, Federico Pessina, Elena Clerici, et al.
Journal of Neuro-Oncology
|
June 5, 2015
Hypofractionated stereotactic radiation therapy in skull base meningiomas
Pierina Navarria, Federico Pessina, Luca Cozzi, et al.
The Journal of Biological Chemistry
|
July 3, 2003
Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor
Lior Zilberberg, Svetlana Shinkaruk, Olivier Lequin, et al.
Analytical Cellular Pathology (Amsterdam)
|
December 14, 2011
Differential signature of the centrosomal MARK4 isoforms in glioma
Ivana Magnani, Chiara Novielli, Laura Fontana, et al.
Oncotarget
|
October 6, 2017
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
Pierina Navarria, Federico Pessina, Stefano Tomatis, et al.
Neuro-Oncology
|
October 13, 2020
Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas
Marco Rossi, Lorenzo Gay, Federico Ambrogi, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
Journal of Neurosurgery
|
May 18, 2019
Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome
Marco Rossi, Federico Ambrogi, Lorenzo Gay, et al.
Neuro-Oncology
|
October 15, 2021
IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups
Roberta Rudà, Francesco Bruno, Tamara Ius, et al.
Radiation Oncology (London, England)
|
June 3, 2016
Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection
Pierina Navarria, Federico Pessina, Luca Cozzi, et al.
World Neurosurgery
|
February 25, 2019
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors
Marco Riva, Egesta Lopci, Antonella Castellano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2019
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study
Pierina Navarria, Federico Pessina, Elena Clerici, et al.
Journal of Neuro-Oncology
|
June 5, 2015
Hypofractionated stereotactic radiation therapy in skull base meningiomas
Pierina Navarria, Federico Pessina, Luca Cozzi, et al.
The Journal of Biological Chemistry
|
July 3, 2003
Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor
Lior Zilberberg, Svetlana Shinkaruk, Olivier Lequin, et al.
Analytical Cellular Pathology (Amsterdam)
|
December 14, 2011
Differential signature of the centrosomal MARK4 isoforms in glioma
Ivana Magnani, Chiara Novielli, Laura Fontana, et al.
Oncotarget
|
October 6, 2017
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
Pierina Navarria, Federico Pessina, Stefano Tomatis, et al.
Neuro-Oncology
|
October 13, 2020
Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas
Marco Rossi, Lorenzo Gay, Federico Ambrogi, et al.
Page
of 19